IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v3y2021i6id41076.html

Vaccines for the COVID-19 α Variant: An Econometric Analysis

Author

Listed:
  • James McIntosh

    (Concordia University, Canada)

Abstract

This study examines the success of COVID-19 vaccines in four European countries and Israel for the α variant. These countries respond to the vaccines with varying degrees of success. Countries with successful vaccination programs take about 160 days to get to the minimum number of new cases. Only Italy and Israel came close to eradicating the virus. Vaccines and previous infections have a similar prophylactic effect on new infections. Second doses for the most part add little protection to those who have only one dose. Vaccines become very effective after seven days although there are some added benefits that accrue to individuals in the second week after vaccination. The effect of vaccines on new cases is non-linear and exhibits a decreasing marginal effect. COVID-19 is spread by asymptomatic carriers, a feature of the disease which was discernable at the same time that public health agencies were discouraging the use of masks by the general public and downplaying the importance of social distancing. These were major policy errors and led to many unnecessary deaths.

Suggested Citation

  • James McIntosh, 2021. "Vaccines for the COVID-19 α Variant: An Econometric Analysis," European Journal of Medical and Health Sciences, European Open Science, vol. 3(6), pages 64-67, November.
    • Handle: RePEc:epw:ejmed0:v:3:y:2021:i:6:id:41076
    DOI: 10.24018/ejmed.2021.3.6.1076
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/41076
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/41076/9393
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2021.3.6.1076?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:3:y:2021:i:6:id:41076. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.